Friday, May 1, 2026

“Putin’s Closest Associate” Medvedev, New Year Congratulatory Telegram To Kim Jong-un…”Expectation Of New Possibilities”

Medvedev's visit to North Korea highlights strengthening ties and future cooperation between Russia and North Korea.

IVE Takes Over Europe: A Breakdown of Their First Tour

K-pop sensation IVE has completed their first...

North Korean Hackers Target Defense Companies as Fake Recruiters

A North Korean hacking organization reportedly attempted to hack defense companies worldwide by disguising themselves as recruiters.

Tag: loss

New Obesity Drug Shows Big Promise — and It’s Not from Eli Lilly or Novo

Metsera leads emerging obesity treatments with promising drug MET-233i, showing significant weight loss in trials, amid rising competition.

Apple’s $3 Trillion Status Crashes After Trump Warning

Trump's tariff threat leads to a drop in Apple's stock, compounding challenges like declining Chinese sales and talent loss.

Dark Skin Patches in Teens? It Could Be a Warning Sign, Doctors Say

Dark patches on skin folds in adolescents may indicate Acanthosis Nigricans, linked to obesity and insulin resistance. Consult a specialist.

Nvidia Lost Half Its China Market—Now It’s Paying the Price

Nvidia CEO Jensen Huang criticized U.S. export controls on H20 chips to China, citing revenue losses and market share decline.

New Study: Mounjaro Helps Users Drop Over 50 Pounds

Eli Lilly's Mounjaro leads U.S. obesity drug market, outperforming semaglutide in weight loss efficacy and safety.

Digital Dementia Is Real—And It’s Hitting Millennials and Gen Z

Increased reliance on digital devices among youth leads to memory loss and cognitive decline, raising concerns over 'digital dementia.'

Eli Lilly’s Oral GLP-1 Shows 7.9% Weight Loss in Type 2 Diabetes Trial

Eli Lilly's orforglipron shows promise in Phase 3 trials for diabetes and obesity, offering an oral alternative to injectables.

Top News

- Our Sponsors Ad -

Follow us